USA - NASDAQ:BCTX - CA1079303071 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to BCTX. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-04-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-03 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-12-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-19 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-09-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-12-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-10-03 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-06-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-02-24 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-02-14 | HC Wainwright & Co. | Initiate | Buy |
The consensus rating for BRIACELL THERAPEUTICS CORP (BCTX) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering BRIACELL THERAPEUTICS CORP (BCTX) is 5.